Clinical Trials Directory

Trials / Completed

CompletedNCT00410085

Renal Hemodynamics and Tubular Function in Patients With Obstructive Sleep Apnea and Healthy Controls

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (planned)
Sponsor
Regional Hospital Holstebro · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

Nitrogen-oxide (NO) plays an important role for blood pressure regulation, renal hemodynamics, and the renal excretion of sodium. NO is synthesized from L-arginine in the vascular endothelium and have a very short half-life in plasma and is therefore very difficult to measure directly. L-mono-methyl-L-arginine (L-NMMA) is an analogue to L-arginine and a competitive inhibitor of NO, and therefore can be used to study the effect of NO on the circulation. In normal subjects, infusion of L-NMMA will cause an increase in blood pressure, decreased renal plasma-flow, decreased glomerular filtration rate, and a decreased excretion of sodium. Hypothesis: Patients with obstructive sleep apnea has a decreased activity in the NO-system. This is contributing to the hypertension often seen in these patients. Decreased activity in the NO-system can be revealed by diminished fall in renal hemodynamic and sodium excretion after infusion of L-NMMA.

Conditions

Interventions

TypeNameDescription
DRUGL-NMMA (N-mono.methyl-L-arginine)

Timeline

Start date
2005-01-01
Completion
2005-11-01
First posted
2006-12-12
Last updated
2008-04-22

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00410085. Inclusion in this directory is not an endorsement.